Sample size determination for phase II studies of new vaccines

Vaccine

Volumn 20, Issue 27-28, 2002, Pages 3364-3369

  Rao, Malla R ^a   Blackwelder, William C ^b   Troendle, James F ^a   Naficy, Abdollah B ^b   Clemens, John D ^a,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c International Vaccine Institute   (South Korea)

Author keywords

Clinical trials; Sample size; Vaccine

Indexed keywords

VACCINE;

ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; DRUG SCREENING; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; SAMPLE SIZE;

CHOLERA VACCINES; CLINICAL PROTOCOLS; CLINICAL TRIALS, PHASE II; HUMANS; SAFETY; SAMPLE SIZE; VACCINES;

EID: 0037056016     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00317-1     Document Type: Article

References (15)

1. Lachin J.M. Introduction to sample size determination and power analysis for clinical trialsm. Control. Clin. Trials. 2(2):1981;93-113.
2. Blackwelder WC, Equivalence trials. In: Redmond CK, Colton T, editors. Biostatistics in clinical trials. New York: Wiley, 2001. p. 179-85.
3. ICH E9 Expert Working Group. ICH harmonized tripurtite guideline: Statistical principles for clinical trials. Stat Med 1999;18:1905-42.
4. Farrington C.P., Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat. Med. 9:1990;1447-1454.
5. Gart J.J., Nam J.M. Approximate interval estimation of the difference in binomial parameters: correction for skewness and extension to multiple tables. Biometrics. 46(3):1990;637-643.
6. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat. Med. 17(8):1998;873-890.
7. Roebruck P., Kuhn A. Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities. Stat. Med. 14:1995;1583-1594.
8. Blackwelder W.C. "Proving the null hypothesis" in clinical trials. Control. Clin. Trials. 3:1982;345-353.
9. Fleming T.R. Design and interpretation of equivalence trials. Am. Heart J. 139(4):2000;S171-6.
10. Altman D.G., Bland J.M. Absence of evidence is not evidence of absence. BMJ. 311(7003):1995;485.
11. Rothman K.J. A show of confidence [editorial]. N. Engl. J. Med. 299:1978;1362-1363.
12. Borenstein M. The case for confidence intervals in controlled clinical trials. Control. Clin. Trials. 15(5):1994;411-428.
13. Jolley D. The glitter of the t table. Lancet. 342(8862):1993;27-29.
14. Greene W.L., Concato J., Feinstein A.R. Claims of equivalence in medical research: are they supported by the evidence? Ann. Intern. Med. 132(9):2000;715-722.
15. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A.et al. A controlled trial of two acellular vaccines and one whole cell vaccine against pertusis. Progetto Pertusse Group. N. Engl. J. Med. 334(6):1996;341-348.